(EMXC) MSCI Emerging Ex China Acc - Overview
Etf: Equity, Emerging, Ex-China, Diversified
| Risk 5d forecast | |
|---|---|
| Volatility | 14.3% |
| Relative Tail Risk | -0.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.29 |
| Alpha | 23.77 |
| Character TTM | |
|---|---|
| Beta | 0.156 |
| Beta Downside | 0.394 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.48% |
| CAGR/Max DD | 0.87 |
Description: EMXC MSCI Emerging Ex China Acc January 20, 2026
The Amundi MSCI Emerging Markets ex-China UCITS ETF (ticker EMXC, listed on XETRA) tracks the Morningstar Emerging Markets ex-China Total Market Index (NR USD), offering investors exposure to a diversified basket of non-Chinese equities across 23 emerging-market economies. The fund is domiciled in Germany and classified under the “Global Emerging Markets ex-China Equity” ETF category.
Key quantitative drivers (as of the most recent data cut-off, Q4 2024) include an expense ratio of 0.20 % p.a., a weighted average market-cap of roughly USD 5 billion, and a sector tilt toward financials (≈ 30 % of assets) and consumer discretionary (≈ 20 %). The underlying index is heavily influenced by macro-factors such as commodity price cycles, domestic consumption growth in India and Brazil, and policy-driven credit expansion in Southeast Asia, which together account for the majority of the fund’s performance variance.
If you want a deeper, data-rich view of EMXC’s risk-adjusted returns and scenario analysis, a quick look at ValueRay’s platform can help you surface the numbers you need.
What is the price of EMXC shares?
Over the past week, the price has changed by +1.86%, over one month by +5.79%, over three months by +14.03% and over the past year by +29.66%.
Is EMXC a buy, sell or hold?
What are the forecasts/targets for the EMXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 38.1 | 15.4% |
EMXC Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 939.5m EUR (939.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 939.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 939.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.49% (E(939.5m)/V(939.5m) * Re(6.49%) + (debt-free company))
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)